Converge Technology Solutions Corp.

TSX:CTS Stok Raporu

Piyasa değeri: CA$648.7m

Converge Technology Solutions Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 2/6

Converge Technology Solutions şu anki getirisi 1.79% olan temettü ödeyen bir şirkettir. Bir sonraki ödeme tarihi olan 27th December, 2024 temettüden önceki tarihi 10th December, 2024 dir.

Anahtar bilgiler

1.8%

Temettü verimi

8.5%

Geri Alım Getirisi

Toplam Hissedar Getirisi10.3%
Gelecekteki Temettü Verimin/a
Temettü Büyümesi20.8%
Bir sonraki temettü ödeme tarihi27 Dec 24
Eski temettü tarihi10 Dec 24
Hisse başına temettüCA$0.060
Ödeme oranı-6%

Son temettü ve geri alım güncellemeleri

Converge Technology Solutions' (TSE:CTS) Dividend Will Be CA$0.015

Nov 15
Converge Technology Solutions' (TSE:CTS) Dividend Will Be CA$0.015

Recent updates

Some Converge Technology Solutions Corp. (TSE:CTS) Shareholders Look For Exit As Shares Take 25% Pounding

Nov 16
Some Converge Technology Solutions Corp. (TSE:CTS) Shareholders Look For Exit As Shares Take 25% Pounding

Converge Technology Solutions' (TSE:CTS) Dividend Will Be CA$0.015

Nov 15
Converge Technology Solutions' (TSE:CTS) Dividend Will Be CA$0.015

Is Converge Technology Solutions (TSE:CTS) Using Too Much Debt?

Sep 04
Is Converge Technology Solutions (TSE:CTS) Using Too Much Debt?

Pinning Down Converge Technology Solutions Corp.'s (TSE:CTS) P/S Is Difficult Right Now

Jun 21
Pinning Down Converge Technology Solutions Corp.'s (TSE:CTS) P/S Is Difficult Right Now

We Think Converge Technology Solutions (TSE:CTS) Is Taking Some Risk With Its Debt

May 23
We Think Converge Technology Solutions (TSE:CTS) Is Taking Some Risk With Its Debt

Is Converge Technology Solutions Corp. (TSE:CTS) Trading At A 49% Discount?

May 02
Is Converge Technology Solutions Corp. (TSE:CTS) Trading At A 49% Discount?

Capital Allocation Trends At Converge Technology Solutions (TSE:CTS) Aren't Ideal

Apr 11
Capital Allocation Trends At Converge Technology Solutions (TSE:CTS) Aren't Ideal

Converge Technology Solutions Corp. (TSE:CTS) Held Back By Insufficient Growth Even After Shares Climb 28%

Mar 16
Converge Technology Solutions Corp. (TSE:CTS) Held Back By Insufficient Growth Even After Shares Climb 28%

Converge Technology Solutions Corp.'s (TSE:CTS) Share Price Is Matching Sentiment Around Its Revenues

Jan 31
Converge Technology Solutions Corp.'s (TSE:CTS) Share Price Is Matching Sentiment Around Its Revenues

Is Converge Technology Solutions (TSE:CTS) Using Too Much Debt?

Nov 08
Is Converge Technology Solutions (TSE:CTS) Using Too Much Debt?

Some Investors May Be Worried About Converge Technology Solutions' (TSE:CTS) Returns On Capital

Oct 18
Some Investors May Be Worried About Converge Technology Solutions' (TSE:CTS) Returns On Capital

Should You Investigate Converge Technology Solutions Corp. (TSE:CTS) At CA$2.59?

Aug 11
Should You Investigate Converge Technology Solutions Corp. (TSE:CTS) At CA$2.59?

Here's What's Concerning About Converge Technology Solutions' (TSE:CTS) Returns On Capital

May 31
Here's What's Concerning About Converge Technology Solutions' (TSE:CTS) Returns On Capital

Is There Now An Opportunity In Converge Technology Solutions Corp. (TSE:CTS)?

May 11
Is There Now An Opportunity In Converge Technology Solutions Corp. (TSE:CTS)?

We Like These Underlying Return On Capital Trends At Converge Technology Solutions (TSE:CTS)

Feb 11
We Like These Underlying Return On Capital Trends At Converge Technology Solutions (TSE:CTS)

Should You Be Adding Converge Technology Solutions (TSE:CTS) To Your Watchlist Today?

Jan 20
Should You Be Adding Converge Technology Solutions (TSE:CTS) To Your Watchlist Today?

Is Now The Time To Look At Buying Converge Technology Solutions Corp. (TSE:CTS)?

Jan 04
Is Now The Time To Look At Buying Converge Technology Solutions Corp. (TSE:CTS)?

Converge Technology Solutions (TSE:CTS) Has A Pretty Healthy Balance Sheet

Nov 29
Converge Technology Solutions (TSE:CTS) Has A Pretty Healthy Balance Sheet

Converge Technology Solutions (TSE:CTS) Is Looking To Continue Growing Its Returns On Capital

Oct 04
Converge Technology Solutions (TSE:CTS) Is Looking To Continue Growing Its Returns On Capital

We Ran A Stock Scan For Earnings Growth And Converge Technology Solutions (TSE:CTS) Passed With Ease

Sep 16
We Ran A Stock Scan For Earnings Growth And Converge Technology Solutions (TSE:CTS) Passed With Ease

Converge Technology Solutions (TSE:CTS) Has A Pretty Healthy Balance Sheet

Aug 29
Converge Technology Solutions (TSE:CTS) Has A Pretty Healthy Balance Sheet

Converge Technology Solutions Corp.'s (TSE:CTS) 32% Jump Shows Its Popularity With Investors

Aug 11
Converge Technology Solutions Corp.'s (TSE:CTS) 32% Jump Shows Its Popularity With Investors

Yaklaşan Temettü Ödemesi

BugünNov 20 2024Eski Temettü TarihiDec 10 2024Temettü Ödeme TarihiDec 27 202417 days Eski TemettüdenGelecek temettüyü almak için bir sonraki 19 days adresinden satın alın

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: Temettü ödemeleri istikrarlı olsa da CTS 10 yıldan az bir süredir temettü ödüyor.

Büyüyen Temettü: CTS şirketinin temettü ödemeleri artmış, ancak şirket yalnızca 2 yıldır temettü ödemiştir.


Piyasaya Karşı Temettü Getirisi

Converge Technology Solutions Piyasaya Karşı Temettü Getirisi
CTS temettü verimi piyasa ile karşılaştırıldığında nasıldır?
SegmentTemettü Verimi
Şirket (CTS)1.8%
Pazarın Alt %25'i (CA)1.8%
Pazarın En İyi %25'i (CA)6.1%
Sektör Ortalaması (IT)2.2%
Analist tahmini (CTS) (3 yıla kadar)n/a

Önemli Temettü: CTS 'in temettüsü ( 1.79% ), Canadian piyasasındaki temettü ödeyenlerin en alttaki %25'inden ( 1.77% ) daha yüksektir.

Yüksek Temettü: CTS 'in temettüsü ( 1.79% ), Canadian piyasasındaki temettü ödeyenlerin en üst %25'ine ( 6.11% ) kıyasla düşüktür.


Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: CTS temettü ödüyor ancak şirket kâr etmiyor.


Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Düşük nakit ödeme oranı ( 3.6% ) sayesinde CTS 'un temettü ödemeleri nakit akışları tarafından tamamen karşılanmaktadır.


Güçlü temettü ödeyen şirketleri keşfedin